Application Note: Overcoming Obstacles to Develop a Cancer Immunotherapeutic
19 August 2014

This application notes describes the events which have lead to Dr. Brenner and MaxCyte being currently engaged in a Phase I/II clinical trial to assess the safety of escalating doses of an immunotherapeutic using MaxCyte’s cell loading system.

Download PDF >>PDF Icon

Read the full article...

  Become a member
  • Quick and complete access to all application articles

  • Download 10,000+
    applications and methods

  • Make informed buying decisions

Already a member?

Log in for full access to the article

Remember me